Mediclinic International PLC (LON:MDC) had its price objective dropped by equities researchers at HSBC from GBX 920 ($11.49) to GBX 745 ($9.31) in a research note issued to investors on Friday. The firm presently has a “reduce” rating on the stock. HSBC’s price objective would suggest a potential upside of 0.68% from the company’s previous close.

Other research analysts have also issued reports about the stock. Jefferies Group raised their target price on shares of Mediclinic International PLC from GBX 833 ($10.41) to GBX 920 ($11.49) and gave the company a “hold” rating in a report on Tuesday, July 26th. Citigroup Inc. lowered shares of Mediclinic International PLC to a “neutral” rating and set a GBX 1,090 ($13.62) target price for the company. in a report on Monday, September 12th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a GBX 1,160 ($14.49) target price on shares of Mediclinic International PLC in a report on Tuesday, August 23rd. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. Mediclinic International PLC presently has an average rating of “Hold” and a consensus price target of GBX 949 ($11.86).

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Shares of Mediclinic International PLC (LON:MDC) opened at 752.00 on Friday. The stock has a 50 day moving average of GBX 895.40 and a 200-day moving average of GBX 959.22. Mediclinic International PLC has a 52-week low of GBX 729.00 and a 52-week high of GBX 1,184.00. The stock’s market capitalization is GBX 5.54 billion.

The firm also recently announced a dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 24th will be given a dividend of GBX 3.20 ($0.04) per share. The ex-dividend date is Thursday, November 24th. This represents a dividend yield of 0.41%.

About Mediclinic International PLC

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.